Professor Daniel HS Lee

Associate Vice-President (Innovation and Enterprise)
Honorary professor, School of Biomedical Sciences

BSc (Hons), (HKU); PhD, Pathology (HKU)

Curriculum Vitae

Education

Employment

2019-present, Associate Vice President (Innovation & Enterprise), The Chinese University of Hong Kong
2019-present, Honorary Professor, Chinese University of Hong Kong
2013-present, Adjunct Professor, University of Hong Kong Science and Technology
2013-2018, Biomedical Technology Cluster Head, Hong Kong Science & Technology Parks Corporation
2010-present, Honorary Professor, Faculty of Medicine, University of Hong Kong
2010-2013, General Manager and site Head, Roche Pharma Research and Early Development China, Shanghai
2008-2010, Senior Director and Head, Translational Medicine, Senior Director, Neurodegeneration, Global co-Director, Rare Diseases, GlaxoSmithKline China, Shanghai
2000-2008, Program Leader, Biogen Inc USA, Boston
1991-2000, Senior Scientist, Johnson & Johnson USA, Philadelphia
1989-1990, Visiting Scientist, Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada
1983-1990, Staff Tutor, Clinical Biochemistry Unit, Queen Mary Hospital, University of Hong Kong

Alzheimer’s disease, advanced therapeutics, drug discovery and development, bioinformatics, translational medicine, Ph I/II clinical trial design

Active, Ad hoc Journal reviewer
2020-present, Innovation and Technology Commission ITF Research Project Assessment Panel
2019-present, Logistic and Supply Chain Multitech Board member,
2019, Organizing Committee member, First Human Genome Editing Conference
2018-present, International Human Epigenetics Ethics Committee member
2018-present, Life Science Society Advisor
2015-2019, Clinical Trials Center, Chinese University of Hong Kong, Advisor
2013-present, School of Pharmacy, Chinese University of Hong Kong, Advisory Board member
2001-present, Alzheimer’s Association USA Grant reviewer